Compare USAC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USAC | TWST |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.0B |
| IPO Year | 2011 | 2018 |
| Metric | USAC | TWST |
|---|---|---|
| Price | $27.21 | $43.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $26.67 | ★ $48.75 |
| AVG Volume (30 Days) | 179.6K | ★ 1.1M |
| Earning Date | 05-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.65% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $698,365,000.00 | $376,572,000.00 |
| Revenue This Year | $33.55 | $18.89 |
| Revenue Next Year | $6.83 | $15.28 |
| P/E Ratio | $31.25 | ★ N/A |
| Revenue Growth | 19.51 | ★ 20.32 |
| 52 Week Low | $21.59 | $23.30 |
| 52 Week High | $28.09 | $57.88 |
| Indicator | USAC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 42.10 |
| Support Level | $22.62 | $42.89 |
| Resistance Level | N/A | $45.76 |
| Average True Range (ATR) | 0.74 | 2.63 |
| MACD | -0.10 | -0.83 |
| Stochastic Oscillator | 49.70 | 6.34 |
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.